| Title： | Chinese experts consensus on clinical application of low molecular weight heparin |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Clinician, Pharmacists and other relevant medical personnel in various medical institutions, and managers of health department and administrative department in charge of medical insurance. |
| Evidence classification method： | The GRADE method was used to grade the quality of evidence and the strength of recommended opinions. |
| Development unit： | Precision Pharmacy Working Committee of the Chinese Pharmacists Association |
| Registration time: | 2023-11-21 |
| Registration number： | PREPARE-2023CN929 |
| Purpose of the guideline: | The consensus is formulated based on the relevant provisions of laws and regulations and the best available evidence, mainly to provide consistency, uniformity and standardized consensus on standards for the clinical rational application of hepatoprotective drugs, promote the rational use of drugs, and ensure the safety of drug use for patients. |
